CKD to patent an anti-sepsis drug, CKD-712 in Korea.

Published: 2005-09-28 06:58:00
Updated: 2005-09-28 06:58:00
Chongkundang (CKD) announced on Sept. 22 that CKD-712, an antibacterial agent for the treatment of sepsis and a derivative of Tetrahydroisoquinolone compounds and its manufacturing process had completed to patent in Korea.

The active ingredient has been developed by over 3 billion won of inves...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.